All Stories

  1. Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL
  2. Higher concentration insulins: an overview of clinical considerations
  3. How much is too much? Outcomes in patients using high‐dose insulin glargine